Naturally occurring peptides for gastroprotection: stable gastric pentadecapeptide BPC 157
We focused on the stable gastric pentadecapeptide BPC 157 as an essential cytoprotective agent. Noteworthy, the category of cytoprotective drugs was largely expanded since original Robert’s description (stomach cell protection against gastric lesion induced by one gastric acid secretion (GAS) non-dependent necrotizing challenge) to different antiulcer ...
Seiwerth, Sven +2 more
openaire +2 more sources
We focused on abdominal aorta, clamped and transected bellow renal arteries, and aortic termino-terminal anastomosis created in Albino male rats. We suggested stomach cytoprotection theory holding endothelium protection and peptidergic anti-ulcer cytoprotection therapy to improve management of abdominal aorta anastomosis and thrombus formation.
Hrelec, Maša +6 more
openaire +3 more sources
Complex Syndrome of the Complete Occlusion of the End of the Superior Mesenteric Vein, Opposed with the Stable Gastric Pentadecapeptide BPC 157 in Rats. [PDF]
Knezevic M +28 more
europepmc +1 more source
Acute Compartment Syndrome and Intra-Abdominal Hypertension, Decompression, Current Pharmacotherapy, and Stable Gastric Pentadecapeptide BPC 157 Solution. [PDF]
Sikiric P +18 more
europepmc +1 more source
Bowel adhesion and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine in rats. [PDF]
Cesar LB +12 more
europepmc +1 more source
From Selye's and Szabo's Cysteamine-Duodenal Ulcer in Rats to Dopamine in the Stomach: Therapy Significance and Possibilities. [PDF]
Sikiric P +24 more
europepmc +1 more source
Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome. [PDF]
Sikiric P +12 more
europepmc +1 more source
Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine. [PDF]
Amic F +18 more
europepmc +1 more source
BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers. [PDF]
Mateescu DM +9 more
europepmc +1 more source
BPC-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase. [PDF]
Jelińska J +7 more
europepmc +1 more source

